Sign in

CIK 0001357874

  • Non-accelerated filer
  • Smaller reporting company

PRECISION BIOSCIENCES INC

Sign in to watch
Ticker
DTIL
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
May 21
Incorporated
DE
Entity type
Operating
Phone
+1 919-314-5512
Business address
302 EAST PETTIGREW STREET, SUITE A-100, DURHAM, NC, 27701
  1. 4 Open-market buy Director bought 3,605 shares at $4.49 ($16,186)
  2. 4 Open-market buy Director bought 4,320 shares at $4.88 ($21,082)
  3. 4 Open-market buy Chief Financial Officer bought 2,113 shares at $4.75 ($10,037)
  4. 4 Open-market buy Director bought 3,016 shares at $4.55 ($13,723)
  5. 4 Open-market buy Chief Financial Officer bought 3,000 shares at $6.76 ($20,280)
  6. 4 Exercise or conversion Chief Financial Officer acquired 3,605 shares (option exercise)
  7. 4 Planned sale General Counsel and Secretary sold 588 shares at $8.19 ($4,816)
  8. 4 Open-market sale President and CEO sold 3,012 shares at $8.19 ($24,668)
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 4 Derivatives Options or other derivatives
  12. 4 Derivatives Options or other derivatives
  13. 4 Planned sale General Counsel and Secretary sold 93 shares at $11.79 ($1,096)
  14. 4 Exercise or conversion Chief Financial Officer acquired 454 shares (option exercise)
  15. 4 Open-market sale Chief Research Officer sold 50 shares at $11.79 ($590)
  16. 4 Derivatives Options or other derivatives
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 4 of 14 · 269 filings